<DOC>
	<DOCNO>NCT01791062</DOCNO>
	<brief_summary>The two-layer bioresorbable HYTOP® matrix consist upper layer highly purified porcine splint-skin contain natural pore , low layer highly purified collagen fleece contain hyaluronan ( HA ) . In study , medical device use evaluate one-step procedure combine microfracturing surgical implantation HYTOP® . HYTOP® support haemostasis articular cartilage defect , act support cell growth three-dimensional scaffold cell differentiation . HYTOP® protect underlie tissue cartilage debridement and/or microfracturing subchondral bone . The primary working hypothesis HYTOP® safe suitable cell-free matrix support haemostasis , cover cartilage lesion eventually enhance cartilage regeneration one-step surgical procedure .</brief_summary>
	<brief_title>Safety Efficacy Study HYTOP® Treatment Focal Chondral Defects .</brief_title>
	<detailed_description />
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Male female patient 18 50 year age . Good general health condition . Signed write informed consent . General anaesthesia justifiable patient medical point view . Focal chondral defect involve femorotibial compartment knee joint localise one compartment large size one HYTOP® patch . Isolated onesided chondral lesion . Cartilage defect classify Outerbridge grade 3 4 . Chondral lesion exceed subchondral bone ( intact subchondral bone ) . Nearly intact chondral structure surround defect , specifically Outerbridge grade 2 less . Corresponding joint area classify maximum Outerbridge grade 2 . Clinical symptom target joint ( pain walk 100 4 11point numerical scale swell lock 'giving way ' ) . Ensured compliance subject whole study period . Treatment investigational product within 4 week prior study entry . Patients know hypersensitivity constituent product component procedure use study . Patients previous treatment study relevant defect site . Cartilage lesion intact shoulder , bipolar correspond involvement bipolar 'kissing ' lesion . Necessity cartilage repair treatment bilateral joint . Patients meniscus lesion , total partial ( 1/3 total volume ) resect meniscus , limited joint mobility , varus/valgus joint malalignment 5 degree insufficient ligament support . Inflammatory joint disease ( e.g . rheumatoid arthritis , Bechterew disease , chondromatosis ) . Infection study relevant site . Osteoarthritis , arthrofibrosis haematopoetic related disease . Study relevant metabolic disease , adipositas ( BMI equal great 30 kilogram per square meter ) . Study relevant neoplastic , neurological mental illness . Study relevant autoimmune disease . Patients elevate risk bleeding . Recent history drug and/or alcohol abuse ( within last 6 month ) . Pregnant lactating female . Participants childbearing age ( premenopausal ) accept use method birth control pearl index 1 % ( e.g . oral contraceptive , vaginal ring , hormonereleasing intrauterine device ( IUD ) , implant , depot syrinx , hormone patch , double barrier method , tubal ligation , vasectomise partner , … ) treatment period first 12 week followup period . Subjects unable understand inform consent high probability non compliance study procedure and/or non completion study accord investigator 's judgement ( e.g . illiteracy , insufficient knowledge local language ) . Subjects capable contract understanding nature , risk , significance implication clinical investigation unable form rational intention light fact . Low probability compliance aftercare rehabilitation scheme . Forbidden concomitant treatment affect evaluation study parameter ( e.g . oral intake chondroitin sulfate , glucosamine , piascledine , i.a . treatment like depot corticosteroid arthroscopic procedure ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cartilage tissue engineering</keyword>
	<keyword>hyaluronan</keyword>
	<keyword>hyaluronic acid</keyword>
</DOC>